The firms are already taking the lion’s share of earnings from the market, as this week’s results will show
Praised for preventing hundreds of thousands of deaths and allowing a return to more normal life, Covid vaccines will also substantially benefit some pharmaceutical companies.
In June, analysts estimated the global market for the vaccines could be worth $70bn (£50bn) this year, but the figure could be even higher as the Delta variant of coronavirus spreads and scientists debate whether people will need booster shots.
Continue reading...source https://www.theguardian.com/business/2021/aug/01/as-delta-spreads-pfizer-and-moderna-get-set-for-a-booster-shot-to-profits
No comments:
Post a Comment